Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ido Wolf

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
The Israel Medical Association Journal : IMAJ|September 12, 2019
The Hormone KL1: A Regulator of Breast Cancer Cell MetabolismBar Davidov, Riva Shmulevich, Ayelet Shabtay, et al.
The Lancet. Oncology|February 3, 2005
Diabetes mellitus and breast cancerIdo Wolf, Siegal Sadetzki, Raphael Catane, et al.
Journal of Pain and Symptom Management|June 18, 2014
Patterns of use of medical cannabis among Israeli cancer patients: a single institution experienceBarliz Waissengrin, Damien Urban, Yasmin Leshem, et al.
Breast Care (Basel, Switzerland)|June 16, 2022
First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti-HER2 Therapy for HER2-Positive Metastatic Breast Cancer Patients in Comparison with Naïve PatientsBarliz Waissengrin, Roni Levin, Ido Wolf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 28, 2021
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [<sup>18</sup>F]FDG PET-CT and relevance to study interpretationDan Cohen, Shir Hazut Krauthammer, Ido Wolf, et al.
The Oncologist|June 1, 2023
Place of Death for Israeli Cancer Patients Over a 20-Year Period: Reducing Hospital Deaths, but Barriers RemainYuval Shalev Many, Pesach Shvartzman, Ido Wolf, et al.
BMC Medical Research Methodology|January 8, 2022
Oncologic patients' misconceptions may impede enrollment into clinical trials: a cross-sectional studyNethanel Asher, Ari Raphael, Ido Wolf, et al.
Integrative Cancer Therapies|March 15, 2021
Kambô-Induced Systemic Inflammatory Response: A Case Report of Acute Disease Progression of CholangiocarcinomaShira Peleg Hasson, Eliya Shachar, Rivka Kessner, et al.
JCO Oncology Practice|April 2, 2021
Pathology Consultation Clinic for Patients With Cancer: Meeting the Clinician Behind the MicroscopeEliya Shachar, Shira P Hasson, Rochelle Fayngor, et al.
Oncogene|August 29, 2022
The role of α-klotho in human cancer: molecular and clinical aspectsHagai Ligumsky, Keren Merenbakh-Lamin, Noa Keren-Khadmy, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
The Israel Medical Association Journal : IMAJ|September 12, 2019
The Hormone KL1: A Regulator of Breast Cancer Cell MetabolismBar Davidov, Riva Shmulevich, Ayelet Shabtay, et al.
The Lancet. Oncology|February 3, 2005
Diabetes mellitus and breast cancerIdo Wolf, Siegal Sadetzki, Raphael Catane, et al.
Journal of Pain and Symptom Management|June 18, 2014
Patterns of use of medical cannabis among Israeli cancer patients: a single institution experienceBarliz Waissengrin, Damien Urban, Yasmin Leshem, et al.
Breast Care (Basel, Switzerland)|June 16, 2022
First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti-HER2 Therapy for HER2-Positive Metastatic Breast Cancer Patients in Comparison with Naïve PatientsBarliz Waissengrin, Roni Levin, Ido Wolf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 28, 2021
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [<sup>18</sup>F]FDG PET-CT and relevance to study interpretationDan Cohen, Shir Hazut Krauthammer, Ido Wolf, et al.
The Oncologist|June 1, 2023
Place of Death for Israeli Cancer Patients Over a 20-Year Period: Reducing Hospital Deaths, but Barriers RemainYuval Shalev Many, Pesach Shvartzman, Ido Wolf, et al.
BMC Medical Research Methodology|January 8, 2022
Oncologic patients' misconceptions may impede enrollment into clinical trials: a cross-sectional studyNethanel Asher, Ari Raphael, Ido Wolf, et al.
Integrative Cancer Therapies|March 15, 2021
Kambô-Induced Systemic Inflammatory Response: A Case Report of Acute Disease Progression of CholangiocarcinomaShira Peleg Hasson, Eliya Shachar, Rivka Kessner, et al.
JCO Oncology Practice|April 2, 2021
Pathology Consultation Clinic for Patients With Cancer: Meeting the Clinician Behind the MicroscopeEliya Shachar, Shira P Hasson, Rochelle Fayngor, et al.
Oncogene|August 29, 2022
The role of α-klotho in human cancer: molecular and clinical aspectsHagai Ligumsky, Keren Merenbakh-Lamin, Noa Keren-Khadmy, et al.
Pageof 13